AM-Pharma Raises “Prelude” Round

AM-Pharma BV, a Dutch developer of improved endogenous proteins, has raised Euro2.5 million in bridge financing from existing backers Forbion Capital Partners and Inventages Venture Capital. The round is a “prelude” to a Series C financing, which VentureWire reports is targeting Euro25 million. www.am-pharma.com